Journal of Gastroenterology and Hepatology,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 1, 2025
To
study
the
corresponding
strategies
to
control
stomach
cancer,
a
comprehensive
assessment
of
disease
burden
is
required.
Herein,
we
present
long-term
trends
in
cancer
China
over
past
three
decades,
as
well
its
epidemiological
features.
We
characterized
using
GBD
2021
methods
and
results,
based
on
prevalence,
incidence,
mortality,
years
life
lost
(YLLs),
lived
with
disability
(YLDs),
disability-adjusted
(DALYs)
estimated
DisMod-MR
2-1.
also
used
joinpoint
age-period-cohort
(APC)
analysis
interpret
characteristics
project
next
decade,
compare
these
global
prevalence
patterns.
The
age-standardized
incidence
(ASIR)
mortality
rates
(ASMR)
both
sexes
changed
from
48.03
(40.21,
56.69)
29.05
(22.42,
36.2)
46.05
(38.88,
54.43)
21.51
(16.66,
26.61)
per
100
000
people
1990
2021.
DALY
rate
decreased
1181.61
(978.38,
1390.89)
501.26
(387.29,
627.98)
average
annual
percentage
change
(AAPC)
for
were
-1.61
(95%
CI:
-1.73,
-1.48),
-0.50
-0.67,
-0.32),
-2.44
-2.62,
-2.26).
effects
age,
period,
cohort
differed.
In
China's
ASIR
ASMR
will
continue
decline.
However,
despite
decrease
overall
remain
significantly
higher
than
average.
be
major
public
health
challenge,
given
country's
large
population
base
aging
population.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
14
Опубликована: Янв. 8, 2024
Pterostilbene
(PTS),
a
naturally
occurring
analog
of
resveratrol
(RSV),
has
garnered
significant
attention
due
to
its
potential
therapeutic
effects
in
treating
inflammatory
and
oncological
diseases.
This
comprehensive
review
elucidates
the
pharmacological
properties,
mechanisms
action,
PTS.
Various
studies
indicate
that
PTS
exhibits
anti-inflammatory,
antioxidant,
antitumour
potentially
making
it
promising
candidate
for
clinical
applications.
Its
influence
on
regulatory
pathways
like
NF-κB
PI3K/Akt
underscores
diverse
strategies
addressing
Additionally,
showcases
favorable
pharmacokinetic
profile
with
better
oral
bioavailability
compared
other
stilbenoids,
thus
enhancing
potential.
Given
these
findings,
there
is
an
increased
interest
incorporating
into
treatment
regimens
cancer-related
conditions.
However,
more
extensive
trials
are
imperative
establish
safety
efficacy
patient
populations.
Egyptian Journal of Medical Human Genetics,
Год журнала:
2025,
Номер
26(1)
Опубликована: Янв. 20, 2025
Abstract
Background
Gastrointestinal
tract
(GIT)
cancers
are
the
most
lethal
with
a
high
incidence
and
poor
prognosis.
Vascular
endothelial
growth
factor
(VEGF)
glycoprotein
plays
an
essential
role
in
tumour
neovascularization,
especially
of
gastrointestinal
tract.
There
numerous
functional
polymorphisms
reported
VEGF
which
lead
to
either
upregulation
or
downregulation
expression.
Objective
The
present
review
focuses
on
influencing
risk
prognosis
various
GIT
cancers.
Method
study
This
systematic
was
done
by
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-analyses
(PRISMA)
guidelines,
Participant,
Intervention,
Comparison,
Outcomes
Studies
(PICOS)
criteria
were
followed
designing
study.
A
total
183
articles
retrieved
from
Google
Scholar,
PubMed
ScienceDirect
using
keywords.
After
full-text
evaluation
applying
literature
selection
criteria,
108
selected
review.
promoter
transcription
binding
sites
(TFBS)
studied
performing
silico
analysis.
Results
article
summarized
findings
studies
associations
effect
cancer
varied
between
different
ethnicities
analysis
revealed
that
alter
TFBS,
leading
attenuation
activity
factors
might
have
importance
development.
Conclusion
is
as
important
biomarker
studying
disease
susceptibility,
progression
Cancer Drug Resistance,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 8, 2025
Metabolic
reprogramming
within
the
tumor
microenvironment
(TME)
plays
a
critical
role
in
driving
drug
resistance
gastrointestinal
cancers
(GI),
particularly
through
pathways
of
fatty
acid
oxidation
and
glycolysis.
Cancer
cells
often
rewire
their
metabolism
to
sustain
growth
reshape
TME,
creating
conditions
such
as
nutrient
depletion,
hypoxia,
acidity
that
impair
antitumor
immune
responses.
Immune
TME
also
undergo
metabolic
alterations,
frequently
adopting
immunosuppressive
phenotypes
promote
progression
reduce
efficacy
therapies.
The
competition
for
essential
nutrients,
glucose,
between
cancer
compromises
functions
effector
cells,
T
cells.
Additionally,
by-products
like
lactate
kynurenine
further
suppress
activity
populations,
including
regulatory
M2
macrophages.
Targeting
glycolysis
presents
new
opportunities
overcome
improve
therapeutic
outcomes
GI
cancers.
Modulating
these
key
has
potential
reinvigorate
exhausted
shift
toward
phenotypes,
enhance
effectiveness
immunotherapies
other
treatments.
Future
strategies
will
require
continued
research
into
metabolism,
development
novel
inhibitors,
clinical
trials
evaluating
combination
Identifying
validating
biomarkers
be
crucial
patient
stratification
treatment
monitoring.
Insights
may
have
broader
implications
across
multiple
types,
offering
avenues
improving
treatment.
Molecular Medicine Reports,
Год журнала:
2025,
Номер
31(4), С. 1 - 34
Опубликована: Фев. 24, 2025
Flavonoids
are
a
group
of
polyphenolic
compounds
distributed
in
vegetables,
fruits
and
other
plants,
which
have
considerable
antioxidant,
anti‑tumor
anti‑inflammatory
activities.
Several
types
gastrointestinal
(GI)
cancer
the
most
common
malignant
tumors
world.
A
large
number
studies
shown
that
flavonoids
inhibitory
effects
on
cancer,
they
recognized
as
class
potential
drugs.
Therefore,
present
review
investigated
molecular
mechanisms
treatment
different
GI
summarized
drug
delivery
systems
commonly
used
to
improve
their
bioavailability.
First,
classification
therapeutic
various
human
diseases
were
briefly
introduced.
Then,
clarify
mechanism
action
body,
metabolic
process
body
associated
signaling
pathways
causing
five
discussed,
well
corresponding
targets
flavonoids.
Finally,
clinical
settings,
poor
water
solubility,
low
permeability
inferior
stability,
lead
absorption
efficiency
vivo.
three
widely
summarized.
Suggestions
for
improving
bioavailability
focus
next
stage
research
also
put
forward.
Microorganisms,
Год журнала:
2024,
Номер
12(5), С. 955 - 955
Опубликована: Май 8, 2024
Digestive
cancers
are
among
the
leading
causes
of
cancer
death
in
world.
However,
mechanisms
development
and
progression
not
fully
understood.
Accumulating
evidence
recent
years
pointing
to
bidirectional
interactions
between
gut
dysbiosis
a
specific
type
gastrointestinal
is
shedding
light
on
importance
this
“unseen
organ”—the
microbiota.
This
review
focuses
local
role
microbiota
imbalance
different
digestive
tract
organs
annexes
related
carcinogenic
mechanisms.
Microbiota
modulation,
either
by
probiotic
administration
or
dietary
changes,
plays
an
important
future
therapies
various
cancers.
Preventing Chronic Disease,
Год журнала:
2024,
Номер
21
Опубликована: Фев. 19, 2024
People
with
chronic
conditions
and
people
colorectal
cancer
(CRC)
may
share
common
risk
factors;
thus,
CRC
screening
is
important
for
conditions.
We
examined
racial
ethnic
differences
in
the
use
of
among
various
numbers
Gastrointestinal
(GI)
cancers,
including
gastric,
liver,
esophageal,
pancreatic,
and
colorectal
represent
significant
global
health
burdens.
Emerging
evidence
suggests
that
dietary
patterns,
particularly
their
inflammatory
oxidative
properties,
may
influence
cancer
risk.
The
Dietary
Inflammatory
Index
(DII)
Oxidative
Balance
Score
(DOBS)
assess
the
effects
of
diets,
respectively.
This
study
aims
to
explore
association
between
DII,
DOBS,
combined
risk
GI
investigates
potential
mediating
roles
serum
albumin
red
cell
distribution
width
(RDW).